Association of complement factor H Y402H gene polymorphism with Alzheimer's disease
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) and age‐related macular degeneration (AMD) share several epidemiological and biochemical features. The present study aimed to assess the possible influence of the AMD‐associated complement factor H (CFH) Y402H (1277T > C) polymorphism on the risk of AD. Caucasian subjects (n = 800) meeting the criteria for probable (n = 717) or definite (n = 83) AD and Caucasian non‐demented controls (n = 1265) were included in this multi‐center case‐control study, in which genotype and allele frequencies of the CFH 1277T > C polymorphism were determined and related to diagnosis, APOE genotype, Mini‐Mental State Examination score (MMSE) and the cerebrospinal fluid (CSF) biomarkers total‐tau (T‐tau), phospho‐tau 181 (P‐tau 181), and β‐amyloid 1–42 (Aβ 1–42). The AMD‐associated CFH genotypes (1277CC and 1277TC) were overrepresented in subjects with AD as compared to control individuals (P = 0.029). Positive C carrier status was associated with an odds ratio (OR) for AD of 1.24 (95% confidence interval [CI] 1.02–1.50). When APOE ε4 carrier status was included in the regression model, this association was even stronger (OR 1.34, 95% CI: 1.08–1.65, P = 0.007). Subgroup analysis showed that the association between CFH C allele positivity and AD was only evident for individuals carrying the APOE ε4 allele. Positive C carrier status was also associated with lower levels of CSF Aβ 1–42 selectively in the control group in an APOE ε4‐independent manner (P = 0.003). In conclusion, the CFH 1277T > C polymorphism seems to influence the risk of AD and there appears to be an interaction between CFH 1277C and APOE ε4 alleles. The CFH 1277C allele may predispose patients for co‐morbidity in AD and AMD. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Complement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Self-citationComplement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449 · cited 4×
“A 1277T>C transition in the CFH gene, resulting in replacement of tyrosine with histidine at position 402 (Y402H) in the protein, increases the risk of AMD two- to fourfold for individuals carrying one 1277C allele (1277TC) and five- to sevenfold for homozygotes (1277CC) [Edwards et al., 2005; Hageman et al., 2005; Ha…”
BackgroundInfluentialComplement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424 · cited 3×
“A 1277T>C transition in the CFH gene, resulting in replacement of tyrosine with histidine at position 402 (Y402H) in the protein, increases the risk of AMD two- to fourfold for individuals carrying one 1277C allele (1277TC) and five- to sevenfold for homozygotes (1277CC) [Edwards et al., 2005; Hageman et al., 2005; Ha…”
BackgroundFranceschi, C., Capri, M., Monti, D., Giunta, S., Olivieri, F., Sevini, F., Panourgia, M. P., Invidia, L., Celani, L., Scurti, M., et al. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.016 · Cited by 2,087
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961 · cited 3×
“A 1277T>C transition in the CFH gene, resulting in replacement of tyrosine with histidine at position 402 (Y402H) in the protein, increases the risk of AMD two- to fourfold for individuals carrying one 1277C allele (1277TC) and five- to sevenfold for homozygotes (1277CC) [Edwards et al., 2005; Hageman et al., 2005; Ha…”
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857 · cited 1×
“For an update on AD susceptibility genes, see the AlzGene data base (http:// www.alzforum.org/res/com/gen/alzgene/default.asp) [Bertram et al., 2007].”
MethodCSF markers for incipient Alzheimer's disease
Blennow, K., & Hampel, H. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00530-1 · Cited by 1,291 · cited 1×
“It is well known that CSF from AD patients exhibits reduced levels of Ab1–42 and it has been suggested that this may reflect the deposition of Ab into senile plaques with lower levels remaining in the CSF [Blennow and Hampel, 2003].”
BackgroundSelf-citationHageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265 · cited 1×
“Similarly to the senile plaques seen in AD, these contain inflammatory mediators, acute-phase reactants and activated components of the complement system [Johnson et al., 2000; Hageman et al., 2001; Johnson et al., 2001; Anderson et al., 2002].”
BackgroundThe neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease
Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1943 · Cited by 1,167 · cited 3×
“…by other groups and in other populations, but the OR of 1.24 (95% CI: 1.02–1.50) in the whole study group and 1.39 (95% CI: 1.05–1.85) in APOE e4-positive individuals is similar in size to other recently reported susceptibility genes, such as SORL1 [Lee et al., 2007; Rogaeva et al., 2007].”
ResultInfluentialA role for local inflammation in the formation of drusen in the aging eye
Anderson, D. H., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01624-0 · Cited by 1,087
Improved discrimination of AD patients using β-amyloid (1-42) and tau levels in CSF
Hulstaert, F., Blennow, K., Ivanoiu, A., Schoonderwaldt, H. C., Riemenschneider, M., Deyn, P. P. D., Bancher, C., Cras, P., Wiltfang, J., Mehta, P. D., et al. (1999) · Neurology · doi:10.1212/wnl.52.8.1555 · Cited by 724 · cited 1×
“The concentrations of total-tau (T-tau), phospho-tau181 (P-tau181) and Ab1–42 were determined in CSF as previously described [Hulstaert et al., 1999; Vanmechelen et al., 2000].”
MethodSelf-citationNSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies
McGeer, P. L., & McGeer, E. G. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.013 · Cited by 498
Activation of the classical complement pathway in brain tissue of Alzheimer patients
McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90843-4 · Cited by 383 · cited 2×
“Many of these acute-phase proteins can be found in the senile plaques characteristic of AD [McGeer et al., 1989b; Rogers et al., 1992; Webster et al., 1997].”
BackgroundZareparsi, S., Branham, K. E. H., Li, M., Shah, S., Klein, R. J., Ott, J., Hoh, J., Abecasis, G. R., & Swaroop, A. (2005) · The American Journal of Human Genetics · doi:10.1086/431426 · Cited by 371
A potential role for immune complex pathogenesis in drusen formation
JOHNSON, L. V., OZAKI, S., STAPLES, M. K., ERICKSON, P. A., & ANDERSON, D. H. (2000) · Experimental Eye Research · doi:10.1006/exer.1999.0798 · Cited by 353 · cited 1×
“Similarly to the senile plaques seen in AD, these contain inflammatory mediators, acute-phase reactants and activated components of the complement system [Johnson et al., 2000; Hageman et al., 2001; Johnson et al., 2001; Anderson et al., 2002].”
BackgroundSepp, T., Khan, J. C., Thurlby, D. A., Shahid, H., Clayton, D. G., Moore, A. T., Bird, A. C., & Yates, J. R. W. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1143 · Cited by 186 · cited 1×
“…British, Australian, Italian, and French studies have reported CFH 1277C allele frequencies in white populations (controls, non-AMD) ranging from 30.2% to 37.1% [Caprioli et al., 2003; Edwards et al., 2005; Souied et al., 2005; Zareparsi et al., 2005; Baird et al., 2006; Sepp et al., 2006].”
BackgroundInfluentialGiannakis, E., Jokiranta, T. S., Male, D. A., Ranganathan, S., Ormsby, R. J., Fischetti, V. A., Mold, C., & Gordon, D. L. (2003) · European Journal of Immunology · doi:10.1002/eji.200323541 · Cited by 166
Cognitive Impairment in the Age-Related Eye Disease Study: AREDS Report No. 16
(2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.4.537 · Cited by 163
Is Age-related Maculopathy Associated with Alzheimer's Disease?: The Rotterdam Study
Klaver, C. C. W., Ott, A., Hofman, A., Assink, J. J. M., Breteler, M. M. B., & de Jong, P. T. V. M. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010105 · Cited by 162 · cited 1×
“Indeed, a few studies have found associations between AD or impaired cognitive function in general and AMD [Klaver et al., 1999; Clemons et al., 2006].”
BackgroundAPOE ε4 allele is associated with reduced cerebrospinal fluid levels of Aβ42
Prince, J. A., Zetterberg, H., Andreasen, N., Marcusson, J., & Blennow, K. (2004) · Neurology · doi:10.1212/01.wnl.0000128088.08695.05 · Cited by 128
Self-citationFarrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124 · cited 1×
“However, the only firmly established genetic risk factor for sporadic AD, so far, is the APOE e4 gene variant [Saunders et al., 1993; Farrer et al., 1997], although other promising candidates, such as the T allele of the Alzheimer’s disease (n¼584) 455 168 459 141 0.909 Control group (n¼160) 675…”
BackgroundInfluential
Cited by
Risk factors and biomarkers of age-related macular degeneration
Lambert, N. G., ElShelmani, H., Singh, M. K., Mansergh, F. C., Wride, M. A., Padilla, M., Keegan, D., Hogg, R. E., & Ambati, B. K. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.04.003 · Cited by 351
Parallel findings in age-related macular degeneration and Alzheimer’s disease
Ohno-Matsui, K. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.02.004 · Cited by 280
“Zetterberg et al. (2008) reported an increased risk of AD for carriers of the AMD-associated CFH C allele.”
BackgroundAge-related macular degeneration (AMD): Alzheimer's disease in the eye?
Kaarniranta, K., Salminen, A., Haapasalo, A., Soininen, H., & Hiltunen, M. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101908 · Cited by 248
“The CFH T1277C allele may predispose patients for co-morbidity in AD and AMD [58].”
Background(2012) · PubMed Central · Cited by 150
Towards the application of precision medicine in Age-Related Macular Degeneration
Cascella, R., Strafella, C., Caputo, V., Errichiello, V., Zampatti, S., Milano, F., Potenza, S., Mauriello, S., Novelli, G., Ricci, F., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.11.004 · Cited by 76
“Supporting these thesis, Zetterberg et al. (2008) found that AMD-associated CC and TC genotypes of rs1061170 were overrepresented in subjects with AD as compared to control individuals (p = 0.029).”
ResultInfluential
Metadata
- Authors
- Zetterberg, M., Landgren, S., Andersson, M. E., Palmér, M. S., Gustafson, D. R., Skoog, I., Minthon, L., Thelle, D. S., Wallin, A., Bogdanovic, N., Andreasen, N., Blennow, K., & Zetterberg, H.
- Venue
- American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Publisher
- Wiley
- Published
- 2008-08-22
- Volume
- 147B
- Issue
- 6
- Pages
- 720-726
- ISSN
- 1552-4841 (ISSN-L)
- 1552-485X
- OpenAlex
- W2119375868
- Cited by
- 88
- References
- 23
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.